Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trialJianxing He, Caicun Zhou, Chunxia Su et al.|The Lancet Respiratory Medicine|2021Cited by 183
Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy LifestyleMeng Zhu, Hongbing Shen, Tianpei Wang et al.|Cancer Research|2021Cited by 121
A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27Mantang Qiu, Lin Xu|Cell Death and Disease|2015Cited by 112
A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinomaCheng Wang, Zhibin Hu, Yayun Gu et al.|Oncogene|2018Cited by 88
KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancerYaqin Wu, Lin Xu|OncoTargets and Therapy|2018Cited by 73